Abstract
Population-based mammographic screening, founded on the premise that ‘early is better than late,’ has been adopted in several countries but has been the subject of controversy since its inception. Findings and interpretation of clinical trials data vary considerably, with disagreement on the outcome and value of such a procedure. In recent years, misgivings are being voiced from many quarters, not just about the benefits but about the potential harms of mass screening. The many are being screened for the benefit of the few. Even this might be acceptable, but the realization that a significant proportion of women with screen detected cancers that will potentially not cause them harm, and who are very likely receiving unnecessary treatment, has sparked further concern. Many are calling for re-assessment of the age of commencement and periodicity if not complete cessation of indiscriminate screening. An aspect of great concern is that screening is being vigorously advocated by many healthcare workers, the media, and lay persons alike without proper awareness or appreciation of the consequences. Although some National Health Department leaflets are now presenting a truer picture, there is still a distinct lack of transparency to allow women to distinguish perception from reality and to make informed choices. How many would elect to be screened if they knew that for every one woman who is notionally saved by early detection, anywhere from 2 to 10 otherwise healthy women are being turned into breast cancer patients?
Similar content being viewed by others
References
Bleyer A, Welch HG (2012) Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367:1998–2005
My medical choice by Angelina Jolie (2013) http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html?_r=0. Accessed 9 Jan 2014
Gigerenzer G (2014) The Art of Risk Communication. Breast cancer screening pamphlets mislead women. BMJ 348:g2636
The Susan G. Komen Breast Cancer Foundation. Consolidated financial statements and supplemental schedules. http://ww5.komen.org/AboutUs/FinancialInformation.html. Accessed 9 Jan 2014
Baum M (2013) Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ 346:f385
Kalager M, Adami HO, Bretthauer M, Tamimi RM (2012) Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 156(7):491–499
Cowan WK, Angus B, Gray JC, Lunt LG, Al-Tamimi SR (2000) A study of interval breast cancer within the NHS breast screening programme. J Clin Pathol 53:140–146
US Preventive Services Task Force (2009) Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 151(10):716–726
Top Mammography Experts Voice Outrage Over New Breast Cancer Screening Recommendations Radiological Society of North America (RSNA) 95th Scientific Assembly and Annual Meeting. http://www.comedsoc.org/images/RSNA%20BrCa%20Screeing%20Panel%2012-4-09.pdf Accessed 11 Jun 2014
http://www.comedsoc.org/Breast_%26_Prostate_Ca_Screening.htm?m=54&s=447. Accessed 11 Jun 2014
Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM, Weaver DL, Geller BM (2013) Registry-based Study of Trends in Breast Cancer Screening Mammography before and after the 2009 US Preventive Services Task Force Recommendations. Radiology. doi:10.1148/radiol.13131063
The Canadian Task Force on Preventive Health Care (2011) Recommendations on screening for breast cancer in average-risk women aged 40–74 years. CMAJ 183(17):1991–2001
Bewley S (2011) Breast cancer screening. The NHS breast screening programme needs independent review. BMJ 343:d6894
Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380:1778–1786
Gøtzsche PC, Nielsen M (2009) Screening for breast cancer with mammography. Cochrane Database Syst Rev 4:CD001877. doi:10.1002/14651858.CD001877.pub3
EUROSCREEN Working Group (2012) Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. Med Screen 19(Suppl 1):5–13. doi:10.1258/jms.2012.012077
Morrell S, Barratt A, Irwig L, Howard K, Biesheuvel C, Armstrong B (2010) Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control 2:275–282
Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E, EUROSCREEN Working Group (2012) Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 19(Suppl 1):42–56
Jørgensen KJ, Gøtzsche PC (2009) Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 339:b2587
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA (2014) Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 348:g366. doi:10.1136/bmj.g366
de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ (2011) Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev 33(1):111–1121
Levman J (2014) Re: accusations of bias versus actual bias regarding mammography. Br Med J 348:g366
Gøtzsche PC (2012) “Benefit and harms of mammography screening, and invitations to screening, Written statement for the UK hearing on mammography screening, 8 March 2012”, http://www.cochrane.dk/screening/StatementforUKPanel.pdf. Accessed 12 Jun 2014
Eusebi V, Feudale E, Foschini MP, Micheli A et al (1994) Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 11:223–235
NHS breast screening: helping you decide. http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp.pdf. Accessed 12 Jan 2014
Breast Screening Programme, England 2009–10 (2014). http://www.hscic.gov.uk/catalogue/PUB01051/brea-scre-prog-eng-2009-2010-rep.pdf. Accessed 12 Jan 2014
Conflict of interest
The author declares that he has no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luqmani, Y.A. Breast screening: an obsessive compulsive disorder. Cancer Causes Control 25, 1423–1426 (2014). https://doi.org/10.1007/s10552-014-0430-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-014-0430-2